C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of GSAP mRNA" | 22698814 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA" | 27188386 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of GSAP mRNA | 21420995 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of GSAP mRNA | 24449571 |
D001507 | Beclomethasone | Beclomethasone results in increased expression of GSAP mRNA | 23656298 |
C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of GSAP mRNA | 26377693 |
D004958 | Estradiol | Estradiol results in decreased expression of GSAP mRNA | 25321415 |
C006780 | bisphenol A | bisphenol A affects the expression of GSAP mRNA | 20170705 |
C006780 | bisphenol A | bisphenol A results in decreased expression of GSAP mRNA | 26063408 |
C006780 | bisphenol A | bisphenol A results in increased expression of GSAP mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of GSAP gene | 28505145 |
C018475 | butyraldehyde | butyraldehyde results in decreased expression of GSAP mRNA | 26079696 |
D002737 | Chloroprene | Chloroprene results in decreased expression of GSAP mRNA | 23125180 |
C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of GSAP mRNA | 19376846 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of GSAP mRNA | 25562108 |
D016572 | Cyclosporine | Cyclosporine results in increased expression of GSAP mRNA | 27989131 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of GSAP mRNA | 27392435 |
D002945 | Cisplatin | Cisplatin results in increased expression of GSAP mRNA | 27594783 |
C000944 | dicrotophos | dicrotophos results in decreased expression of GSAP mRNA | 28302478 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSAP mRNA | 22079256 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of GSAP mRNA | 23649840 |
C039281 | furan | furan results in increased methylation of GSAP gene | 22079235 |
D005897 | Glafenine | Glafenine results in increased expression of GSAP mRNA | 24136188 |
C010974 | glyphosate | glyphosate results in decreased expression of GSAP mRNA | 25636363 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GSAP mRNA | 25613284 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of GSAP mRNA | 27392435 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of GSAP mRNA | 24796395|2675264 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in increased expression of GSAP mRNA | 24231268 |
C045463 | leflunomide | leflunomide results in decreased expression of GSAP mRNA | 28988120 |
D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSAP mRNA | 21641980 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of GSAP mRNA | 28001369 |
C523799 | MRK 003 | MRK 003 results in decreased expression of GSAP mRNA | 21169257 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog affects the expression of GSAP mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of GSAP mRNA" | 25620056 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of GSAP mRNA" | 25620056 |
D010634 | Phenobarbital | Phenobarbital results in decreased expression of GSAP mRNA | 23091169 |
D010634 | Phenobarbital | Phenobarbital results in increased expression of GSAP mRNA | 19270015 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GSAP mRNA | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of GSAP mRNA | 20813756|2381119 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of GSAP mRNA | 23557933 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSAP mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of GSAP mRNA | 22079256 |
D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of GSAP mRNA | 28903501 |
D012822 | Silicon Dioxide | Silicon Dioxide results in decreased expression of GSAP mRNA | 19073995 |
D012999 | Soman | Soman results in increased expression of GSAP mRNA | 19281266 |
D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSAP mRNA | 21641980 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of GSAP mRNA | 20106945|2163298 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GSAP mRNA | 26290441 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GSAP mRNA | 25613284 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of GSAP mRNA | 20133372 |
D014212 | Tretinoin | Tretinoin results in decreased expression of GSAP mRNA | 15894607 |
D014212 | Tretinoin | Tretinoin results in increased expression of GSAP mRNA | 21934132 |
C012589 | trichostatin A | trichostatin A results in decreased expression of GSAP mRNA | 24935251 |
C012589 | trichostatin A | trichostatin A results in increased expression of GSAP mRNA | 24935251 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of GSAP mRNA" | 26179874 |
D014520 | Urethane | Urethane results in decreased expression of GSAP mRNA | 28818685 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of GSAP mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of GSAP mRNA | 23179753|2627250 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of GSAP gene | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of GSAP mRNA | 24935251 |
C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSAP mRNA" | 27188386 |
C111237 | vorinostat | vorinostat results in decreased expression of GSAP mRNA | 26272509 |